Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-26-212434
Filing Date
2026-05-07
Accepted
2026-05-07 17:18:30
Documents
14
Effectiveness Date
2026-05-07

Document Format Files

Seq Description Document Type Size
1 S-8 d112740ds8.htm S-8 49163
2 EX-5.1 d112740dex51.htm EX-5.1 8958
3 EX-23.1 d112740dex231.htm EX-23.1 1750
4 EX-FILING FEES d112740dexfilingfees.htm   iXBRL EX-FILING FEES 20008
5 GRAPHIC g112740g0507032305220.jpg GRAPHIC 3465
  Complete submission text file 0001193125-26-212434.txt   222055

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d112740dexfilingfees_htm.xml XML 10516
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-295664 | Film No.: 26954898
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)